Gilead Sciences Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (428)

Latest Posts

About This Stock More About This Stock
Is Gilead Science A Potential Buy?
Article By: Andreas Gruener
Thursday, February 14, 2019 4:19 AM EST
Currently, the company pays a yearly dividend of 2.52 USD, which equals a yield of 3.85%.
In this article: GILD
Stocks Are Poised To Rise On Feb. 5 As Global Rally Marches On
Article By: Michael J. Kramer
Tuesday, February 5, 2019 8:15 AM EST
The S&P 500 is likely heading higher again today, with the index rising above critical resistance at 2,715 and is on its way to 2,800
In this article: SMH, SPY, XLI, XLK, GILD, SNAP, AMD, GM, SWKS
13 Monster Stock Market Predictions For The Week Of January 28
Article By: Michael J. Kramer
Sunday, January 27, 2019 12:46 PM EST
The week of January 28 will definitely not be a dull one with a monster week for earnings from tech titans and more.
AskSlim Market Week - Saturday, Jan. 5
Video By: Steve Miller
Saturday, January 5, 2019 4:19 PM EST
The stock market began the New Year with huge movements leaving investors jittery as some still call for a bear market and other worry they'll miss huge rallies.
In this video: GILD, BRK-A, AAPL, SPX
Five Stocks To Add In 2019
Article By: Andreas Gruener
Sunday, December 30, 2018 1:33 PM EST
December 2018 is on its way to be one of the worst months ever in the history of the Dow Jones. But this just means there are plenty of new buying opportunities out there.
In this article: ITW, PRU, XOM, AVGO, GILD


Latest Tweets for $GILD

No tweets yet!


Gilead Crohn's Treatment Is Not The Solution To GLD Revenue Issues
Kurt Benson 3/24/2017 10:12:59 PM

I have to agree with your assessment on $GILD. Do you know anything about $VBIO? I read a promising article here about their having a major breakthrough in #Crohn's research.

Not a lot of info on the company though.

Gilead Crohn's Treatment Is Not The Solution To GLD Revenue Issues
Kirk Sheffield 3/24/2017 10:11:55 PM

I think $GILD will rebound. This isn't the only product they have in their pipeline.

Gilead Crohn's Treatment Is Not The Solution To GLD Revenue Issues
Alpha Stockman 3/24/2017 10:07:45 PM

I've been rather disappointed with #Gilead myself. After reading your article, I'm planning to offload some $GILD.

Gilead Sciences Receives Canadian Approval For HIV Drug
David Reynolds 2/20/2017 10:04:11 PM

The opening up of this market for #GileadSciences should bode well for the stock $GILD.

Gilead Sciences: Cheap Growth Or Value Trap?
Karen Klein 9/13/2016 5:39:48 PM

Excellent analysis, you have effectively convinced me to change my position on #Gilead. $GILD

3 Cult Stocks To Avoid In 2015
Bruce Powers 1/26/2015 8:01:06 AM

Great article and glad to read the reasoning to consider $GILD as a safer investment short, mid and long term.

3 Cult Stocks To Avoid In 2015
BreakingBad News 1/25/2015 6:09:51 PM

Sorry all, thanks for the clarification. My bad! Now that I've read it through, it all makes total sense. $GILD, $BAC, $WFM, and $VA are my plays for 2015.

3 Cult Stocks To Avoid In 2015
BreakingBad News 1/25/2015 4:48:08 PM

I'd say this is a minority view, I've seen several others stating that $GILD was a stock to buy this year.

1 to 8 of 8 comments